MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-MP-17-0001960
Market Cap
₹171 Cr
RAAJMEDI · BSE
Share Price
₹102.00
-2.16% today
Revenue
₹80.01 Cr
FY 2025-26 · +28.2% YoY
EBITDA
₹11.76 Cr
Margin 14.7%
Net Profit
₹1.80 Cr
FY 2025-26 · -70.6% YoY
P/E (TTM)
70.8x
P/B 3.6x
ROE
4.9%
ROCE 11.9%
Debt / Equity
1.35
Interest cover 40.7x
About Raaj Medisafe India Limited
Data last updated:
Raaj Medisafe India Limited is a public limited company based in Ujjain, Madhya Pradesh, India. It operates in the medical consumables and supplies segment of the healthcare sector. It was incorporated on 12 September 1985 and has been in existence for over 41 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN L33112MP1985PLC003039. Its GSTIN is 23AABCM1901C1ZD (Madhya Pradesh). The company holds 2 GST registrations, all of them active. It is a listed company as per MCA records. Its shares are listed on BSE: 524502.
The company has an authorised share capital of ₹18 Cr and a paid-up capital of ₹16.42 Cr. It was formerly known as Manoj Surgical Industries Limited. It is led by directors including Arpit Bangur (Managing Director) and Navin Jhawar (Whole-Time Director).
Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 75/2 And 3 Industrial Area Maksi Road, Ujjain, Madhya Pradesh, India – 456010.
As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹80.01 Cr, a growth of 28.2% compared to the previous year. For the same year it recorded a net profit of ₹1.8 Cr (net margin 2.2%) and EBITDA of ₹11.76 Cr (EBITDA margin 14.7%). The net worth stands at ₹46.74 Cr (up 73.6% YoY). Total assets are valued at ₹111.44 Cr (up 81.2% YoY).
The company has about 192 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Raaj Medisafe India and Raaj Medisafe India. As per MCA filings, the company has open charges of ₹113.82 Cr and satisfied charges of ₹24.24 Cr on record. Court records list 5 cases involving the company, including 3 filed by the company and 2 filed against it. The company has 3 deals on record (2 market trades, 1 acquisition); the latest was in March 2023.
Raaj Medisafe India Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MP-17-0001960). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medisafeindia.com.
Company details
CIN L33112MP1985PLC003039
Registration Number 003039
Incorporation Date 12 September 1985
ROC Gwalior
Listing Status Listed - Listed on BSE (524502)
Company Status Active
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-MP-17-0001960
CIN history
Raaj Medisafe India has one previous CIN (Corporate Identification Number): U33112MP1985PLC003039. The current CIN is L33112MP1985PLC003039, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L33112MP1985PLC003039 | Current |
| U33112MP1985PLC003039 | Previous |
Recognitions & Rankings of Raaj Medisafe India
Contact details
Raaj Medisafe India Limited's registered office is in Ujjain, Madhya Pradesh. Its website is medisafeindia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address75/2 And 3 Industrial Area Maksi Road, Ujjain, Madhya Pradesh, India – 456010
- IndustryHealthcare, Medical Consumables & Supplies
To see the full contact details of Raaj Medisafe India Limited, buy the company report.
Comprehensive company report
Raaj Medisafe India Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Raaj Medisafe India operates two associated brands: RAAJ MEDISAFE INDIA and Raaj Medisafe India. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Packaging and hygiene solutions for pharmaceuticals, FMCG, and food industries. | raajmedisafeindia.com | |
| Hygienic disposable products for medical and personal use are manufactured. | medisafeindia.com |
Business activity
The main business activity of Raaj Medisafe India is manufacturing. In detail, this covers plastic products, non-metallic mineral products, rubber products, fabricated metal products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C8 | Plastic products, non-metallic mineral products, rubber products, fabricated metal products |
To see the full business activity and turnover split of Raaj Medisafe India Limited, buy the company report.
Financials of Raaj Medisafe India Limited
FY 2025-26 filings availableRaaj Medisafe India Limited reported revenue of ₹80.01 Cr (up 28.2% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · StandaloneRevenue
₹80.01 Cr
+28.2% YoY
EBITDA
₹11.76 Cr
+36.1% YoY
Profit After Tax
₹1.80 Cr
-70.6% YoY
Net Worth
₹46.74 Cr
+73.6% YoY
Total Assets
₹111 Cr
+81.2% YoY
Total Debt
₹64.67 Cr
+87.1% YoY
Revenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 80.01 | 62.42 | 43.25 | 38.62 | 34.69 | 31.81 | 21.80 |
| Revenue growth | +28.2% | +44.3% | +12.0% | +11.3% | +9.1% | +45.9% | - |
| EBITDA | 11.76 | 8.64 | 6.62 | 5.61 | 5.06 | 4.06 | 1.49 |
| EBITDA margin | +14.7% | +13.8% | +15.3% | +14.5% | +14.6% | +12.8% | +6.8% |
| Profit before tax | 6.32 | 5.26 | 4.27 | 3.77 | 3.73 | 2.63 | 0.01 |
| Net profit | 1.80 | 6.13 | 3.31 | 3.33 | 2.98 | 2.32 | (0.47) |
| Net profit margin | +2.3% | +9.8% | +7.7% | +8.6% | +8.6% | +7.3% | -2.2% |
| EPS (₹) | 1.10 | 4.65 | 3.05 | 3.05 | 2.76 | 2.11 | (0.26) |
| Balance sheet | |||||||
| Total assets | 111 | 61.49 | 36.76 | 23.11 | 17.17 | 14.20 | 10.69 |
| Net worth | 46.74 | 26.92 | 10.83 | 7.49 | 4.15 | 1.07 | (1.19) |
| Total debt | 64.67 | 34.57 | 25.93 | 15.62 | 13.02 | 13.13 | 11.87 |
| Cash & bank | 13.01 | 0.06 | 0.05 | 0.03 | 0.03 | 0.03 | 0.07 |
| Net working capital | 42.84 | 22.12 | 14.65 | 12.92 | 8.13 | 5.41 | 3.61 |
| Cash flow | |||||||
| Cash from operations | 3.67 | (0.09) | 4.27 | 0.17 | 2.45 | 2.23 | (1.03) |
| Cash from investing | (34.95) | (16.42) | (13.00) | (1.67) | (0.96) | (2.78) | (0.21) |
| Cash from financing | 44.23 | 16.52 | 8.74 | 1.49 | (1.47) | 0.51 | 1.24 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 29.46 | 25.08 | 20.71 | 18.40 | 15.83 | 24.40 | 14.59 | 10.91 |
| Revenue growth (YoY) | +86.1% | +2.8% | +42.0% | +68.7% | +45.1% | - | - | - |
| Other income | 0.15 | 0.28 | 0.04 | 0.23 | 0.01 | 0.11 | (0.01) | 0.00 |
| Total expenses | 25.40 | 22.37 | 17.02 | 15.66 | 13.20 | 21.29 | 12.38 | 9.17 |
| EBITDA | 4.06 | 2.71 | 3.69 | 2.74 | 2.63 | 3.11 | 2.21 | 1.74 |
| EBITDA margin | +13.8% | +10.8% | +17.8% | +14.9% | +16.6% | +12.7% | +15.1% | +15.9% |
| Depreciation | 0.71 | 0.63 | 0.50 | 0.43 | 0.49 | 0.44 | 0.40 | 0.23 |
| Interest | 0.86 | 1.08 | 1.38 | 0.82 | 0.68 | 0.68 | 0.52 | 0.36 |
| Profit before tax | 2.64 | 1.28 | 1.85 | 1.72 | 1.47 | 2.10 | 1.28 | 1.15 |
| Tax | 0.66 | 4.52 | (0.05) | 0.00 | 0.00 | (1.37) | 0.25 | 0.18 |
Financial Statements
Figures in ₹ Cr; negatives in brackets. Updated 12 Nov 2026
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 29.46 | 25.08 | 20.71 | 18.40 | 15.83 | 24.40 | 14.59 | 10.91 |
| Revenue growth (YoY) | +86.1% | +2.8% | +42.0% | +68.7% | +45.1% | - | - | - |
| Other income | 0.15 | 0.28 | 0.04 | 0.23 | 0.01 | 0.11 | (0.01) | 0.00 |
| Total expenses | 25.40 | 22.37 | 17.02 | 15.66 | 13.20 | 21.29 | 12.38 | 9.17 |
| EBITDA | 4.06 | 2.71 | 3.69 | 2.74 | 2.63 | 3.11 | 2.21 | 1.74 |
| EBITDA margin | +13.8% | +10.8% | +17.8% | +14.9% | +16.6% | +12.7% | +15.1% | +15.9% |
| Depreciation | 0.71 | 0.63 | 0.50 | 0.43 | 0.49 | 0.44 | 0.40 | 0.23 |
| Interest | 0.86 | 1.08 | 1.38 | 0.82 | 0.68 | 0.68 | 0.52 | 0.36 |
| Profit before tax | 2.64 | 1.28 | 1.85 | 1.72 | 1.47 | 2.10 | 1.28 | 1.15 |
| Tax | 0.66 | 4.52 | (0.05) | 0.00 | 0.00 | (1.37) | 0.25 | 0.18 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 80.01 | 62.42 | 43.25 | 38.62 | 34.69 | 31.81 | 21.80 |
| Revenue growth | +28.2% | +44.3% | +12.0% | +11.3% | +9.1% | +45.9% | - |
| Other income | 0.56 | 0.20 | 0.06 | 0.02 | 0.10 | 0.02 | 0.36 |
| Total expenses | 68.25 | 53.78 | 36.63 | 33.01 | 29.63 | 27.75 | 20.31 |
| Employee cost | 4.34 | 3.37 | 3.25 | 2.70 | 2.89 | 2.44 | 2.15 |
| EBITDA | 11.76 | 8.64 | 6.62 | 5.61 | 5.06 | 4.06 | 1.49 |
| EBITDA margin | +14.7% | +13.8% | +15.3% | +14.5% | +14.6% | +12.8% | +6.8% |
| Depreciation | 2.04 | 1.45 | 0.84 | 0.75 | 0.72 | 0.71 | 0.68 |
| Interest | 3.96 | 2.13 | 1.57 | 1.11 | 0.71 | 0.74 | 1.16 |
| Profit before tax | 6.32 | 5.26 | 4.27 | 3.77 | 3.73 | 2.63 | 0.01 |
| Tax | 4.52 | (0.87) | 0.96 | 0.44 | 0.71 | 0.32 | 0.31 |
| Net profit | 1.80 | 6.13 | 3.31 | 3.33 | 2.98 | 2.32 | (0.47) |
| Net profit margin | +2.3% | +9.8% | +7.7% | +8.6% | +8.6% | +7.3% | -2.2% |
| EPS (₹) | 1.10 | 4.65 | 3.05 | 3.05 | 2.76 | 2.11 | (0.26) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 16.42 | 13.18 | 10.90 | 10.90 | 10.90 | 10.90 | 10.90 |
| Reserves & surplus | 30.32 | 13.74 | (0.07) | (3.41) | (6.75) | (9.83) | (12.09) |
| Shareholders' funds (net worth) | 46.74 | 26.92 | 10.83 | 7.49 | 4.15 | 1.07 | (1.19) |
| Secured loans | 62.25 | 34.51 | 23.28 | 11.93 | 9.78 | 5.75 | 4.59 |
| Unsecured loans | 2.42 | 0.06 | 2.65 | 3.69 | 3.24 | 7.38 | 7.28 |
| Total debt | 64.67 | 34.57 | 25.93 | 15.62 | 13.02 | 13.13 | 11.87 |
| Total liabilities | 111 | 61.49 | 36.76 | 23.11 | 17.17 | 14.20 | 10.69 |
| Assets | |||||||
| Gross block | 51.01 | 33.60 | 19.28 | 16.36 | 16.36 | 13.66 | 13.16 |
| Net block | 39.05 | 23.68 | 10.73 | 8.64 | 9.30 | 7.26 | 7.02 |
| Capital work in progress | 26.76 | 8.51 | 10.14 | 1.59 | 0.00 | 1.60 | 0.00 |
| Investments | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 |
| Inventories | 14.89 | 8.14 | 8.46 | 6.61 | 3.11 | 1.52 | 0.87 |
| Sundry debtors | 11.75 | 16.70 | 7.89 | 6.85 | 5.44 | 4.90 | 4.70 |
| Cash & bank balances | 13.01 | 0.06 | 0.05 | 0.03 | 0.03 | 0.03 | 0.07 |
| Loans & advances | 10.80 | 4.71 | 2.10 | 1.71 | 1.42 | 0.87 | 0.64 |
| Total current assets | 50.45 | 29.61 | 18.50 | 15.20 | 10.00 | 7.32 | 6.28 |
| Total current liabilities | 7.61 | 7.49 | 3.85 | 2.28 | 1.87 | 1.91 | 2.67 |
| Net working capital | 42.84 | 22.12 | 14.65 | 12.92 | 8.13 | 5.41 | 3.61 |
| Total assets | 111 | 61.49 | 36.76 | 23.11 | 17.17 | 14.20 | 10.69 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 0.06 | 0.05 | 0.03 | 0.03 | 0.01 | 0.05 | 0.01 |
| Net cash from operating activities | 3.67 | (0.09) | 4.27 | 0.17 | 2.45 | 2.23 | (1.03) |
| Net cash from investing activities | (34.95) | (16.42) | (13.00) | (1.67) | (0.96) | (2.78) | (0.21) |
| Net cash from financing activities | 44.23 | 16.52 | 8.74 | 1.49 | (1.47) | 0.51 | 1.24 |
| Net change in cash | 12.95 | 0.02 | 0.02 | (0.01) | 0.02 | (0.04) | 0.00 |
| Closing cash | 13.01 | 0.06 | 0.05 | 0.03 | 0.03 | 0.03 | 0.07 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +28.2% | +44.3% | +12.0% | +11.3% | +9.1% | +45.9% | - |
| EBITDA growth | +36.1% | +30.5% | +18.0% | +10.9% | +24.6% | +172.5% | - |
| PBT growth | +20.2% | +23.2% | +13.3% | +1.1% | +41.8% | - | +9998.0% |
| Net income growth | -70.6% | +85.2% | -0.6% | +11.7% | +28.5% | +593.6% | - |
| Revenue CAGR (3Y) | +27.5% | +21.6% | +10.8% | +21.0% | +93.3% | +90.2% | +70.2% |
| EBITDA CAGR (3Y) | +28.0% | +19.5% | +17.7% | +55.6% | - | - | - |
| Profitability & leverage | |||||||
| Net income margin | +2.3% | +9.8% | +7.7% | +8.6% | +8.7% | +7.3% | -1.4% |
| Return on capital employed | +11.9% | +14.6% | +16.9% | +17.3% | +16.5% | +17.9% | 0.0% |
| Return on net worth | +4.9% | +30.1% | +24.1% | +24.1% | +21.8% | +36.4% | 0.0% |
| Debt / equity | 1.35 | 1.60 | 2.27 | 2.46 | 5.01 | 0.00 | 0.00 |
| Long-term debt / equity | 0.70 | 0.68 | 0.78 | 0.43 | 0.63 | 0.00 | 0.00 |
| Interest cover | 40.74 | 29.62 | 27.16 | 22.84 | 16.36 | 22.09 | 143.21 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 1.89 | 2.36 | 2.43 | 2.36 | 2.31 | 2.37 | 2.30 |
| Inventory turnover | 6.95 | 7.52 | 5.74 | 7.95 | 14.98 | 26.62 | 30.28 |
| Debtors turnover | 5.62 | 5.08 | 5.87 | 6.28 | 6.71 | 6.63 | 7.90 |
| EPS (₹) | 1.10 | 4.65 | 3.05 | 3.05 | 2.76 | 2.11 | (0.26) |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 28.46 | 20.42 | 9.94 | 6.87 | 3.81 | 0.98 | (1.09) |
To see the full year-wise statements and ratios of Raaj Medisafe India Limited, buy the company report.
Board of directors of Raaj Medisafe India Limited
Raaj Medisafe India has 6 current directors and 17 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rakesh Agrawal | Director | 09 Aug 2022 | 4 Years 3 Months | Current |
| Navin Jhawar Also directs: Shri Malwa Plastic Packaging Cluster Private Limited | Whole-Time Director | 18 Aug 2021 | 5 Years 2 Months | Current |
| Arpit Bangur | Managing Director | 13 May 2013 | 13 Years 5 Months | Current |
| Krishna Jajoo | Director | 15 Jan 2015 | 11 Years 9 Months | Current |
| Hemant Kasliwal Also directs: Shrivats Paper and Paper Products Private Limited, Kayvee Polyesters Pvt.Ltd., Shree Packers (MP) Private Limited and 4 more | Director | 14 Aug 2024 | 2 Years 2 Months | Current |
| Ateet Agrawal | Director | 14 Aug 2024 | 2 Years 2 Months | Current |
Auditor
Raaj Medisafe India Limited is audited by V.K. LADHA & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V.K. LADHA & ASSOCIATES | FY 2022 | 002301C |
Shareholding
Shareholding for the quarter ended Mar 2026: promoters hold 73.80%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 26.20%.
Mar 2026
QUARTER
73.80% Promoters
26.20% Retail & Others
Promoter holding - history
Now 73.80% · Mar 2026High 73.80% · Sep 2025Low 73.40% · Jun 2025
Shareholding trend - last 6 quarters
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | |
|---|---|---|---|---|
| Promoters | 73.80% | 73.80% | 73.80% | 73.40% |
| Public | 26.20% | 26.20% | 26.20% | 26.60% |
Charges & borrowings
Open charges
₹113.82 Cr
Satisfied charges
₹24.24 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Jun 2026 | 101322778 | Sidbi | ₹1.96 Cr | Open | |
| 14 Nov 2025 | 101191664 | Others | ₹12 Cr | Open | |
| 29 Oct 2025 | 101194928 | Others | ₹20 Lakh | Open | |
| 14 Mar 2024 | 100891925 | Others | ₹49.06 Cr | Open | |
| 12 Jun 2018 | 100184956 | Hdfc Bank Limited | ₹47.9 Cr | Open |
To see the full charge records of Raaj Medisafe India Limited, buy the company report.
Total charge records: 14 View all charges
Deals & funding
Raaj Medisafe India Limited has 3 deals on record (2 market trades, 1 acquisition); the latest was in March 2023.
Total deals
3
Market trades
2
Acquisition
1
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2023 | Market trade | ₹14.7 Lakh | Seller: an individual |
| Oct 2021 | Market trade | ₹37.1 Lakh | Seller: Betarstep Trading Private Limited |
| Mar 2013 | Acquisition | ₹10.9 Lakh | Buyer: Sushen Remedies Private Limited |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Raaj Medisafe India Limited has 5 court cases on record: 3 filed by Raaj Medisafe India, 2 filed against it. All cases are disposed.
Total cases
5
Filed by the company
3
Filed against the company
2
Disposed
5
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 1 | 0 |
| Supreme Court | 1 | 1 | 0 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Thane, Maharashtra | Civil suit | Filed by the company against an individual | Disposed |
| District court, Ahmedabad, Gujarat | Court case (RECO33C 2 LC) | Filed against the company by an individual | Disposed |
| District court, Indore, Madhya Pradesh | Court case (RCS B) | Filed by the company against M/S Skoysan Irnakurlum | Disposed |
| Supreme Court | Court case (1807-Ordinary Civil Matters : Others) | Filed against the company by State of M.P. . | Disposed |
| District court, Indore, Madhya Pradesh | Court case (RCS B) | Filed by the company against an individual | Disposed |
To see the full case history of Raaj Medisafe India Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Raaj Medisafe India Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Raaj Medisafe India Limited has a workforce of 192 employees on its EPFO records as of May 2026, across 2 active EPFO establishments.
Employee count
192
Active EPFO establishments
2
Employee growth
46.6%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 192 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Raaj Medisafe India Limited, buy the company report.
GST
Raaj Medisafe India has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AABCM1901C1ZD | Madhya Pradesh | Active | 01 Jul 2017 |
| 23AABCM1901C2ZC | Madhya Pradesh | Active | 05 Jan 2021 |
To see the full GST registrations and return filing status of Raaj Medisafe India Limited, buy the company report.
Recent activity
Raaj Medisafe India Limited has 39 board changes on record since 1985: 23 appointments and 16 cessations. The latest: Rajesh Kumar Gupta ceased to be Director on 25 Sep 2024.
Charges
A charge with Sidbi amounted to Rs. 1.96 Cr with Charge ID 101322778 was registered on 30 Jun 2026.
Charges
A charge with Others of Rs. 49.06 Cr registered on 14 Mar 2024 with Charge ID 100891925 was modified on 18 Jun 2026.
Filing
Raaj Medisafe India Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Gwalior.
Charges
A charge registered on 25 Sep 2025 via Charge ID 101166322 with Hdfc Bank Limited was fully satisfied on 16 Jan 2026.
Charges
A charge with Others amounted to Rs. 12.00 Cr with Charge ID 101191664 was registered on 14 Nov 2025.
Charges
A charge with Others amounted to Rs. 0.20 Cr with Charge ID 101194928 was registered on 29 Oct 2025.
AGM
Raaj Medisafe India Limited last Annual general meeting of members was held on 25 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 13.59 Cr with Charge ID 101166322 was registered on 25 Sep 2025.
Charges
A charge with Hdfc Bank Limited of Rs. 47.90 Cr registered on 12 Jun 2018 with Charge ID 100184956 was modified on 12 Jun 2025.
Ceased
Rajesh Kumar Gupta ceased to be Director.
Ceased
Vijendra Kumar Sood ceased to be Director.
Appointed
Ateet Agrawal was appointed as Director.
59 earlier events are in the company report.
News
Frequently asked questions
Raaj Medisafe India is an active public limited company based in Ujjain, Madhya Pradesh, India. The company works in medical consumables and supplies, within the healthcare industry. It was incorporated on 12 September 1985 (41+ years old) and is registered under CIN L33112MP1985PLC003039. Listed on BSE: 524502.
Raaj Medisafe India reported revenue of ₹80.01 Cr for FY 2025-26 (up 28.2% YoY) based on standalone financials.
Raaj Medisafe India has 6 current directors:
- Arpit Bangur - Managing Director
- Navin Jhawar - Whole-Time Director
- Rakesh Agrawal - Director
- Krishna Jajoo - Director
- Hemant Kasliwal - Director
- Ateet Agrawal - Director
The latest financial statements of Raaj Medisafe India on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 25 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Raaj Medisafe India is 23AABCM1901C1ZD, registered in Madhya Pradesh. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 23AABCM1901C2ZC (Madhya Pradesh).
The CIN (Corporate Identification Number) of Raaj Medisafe India is L33112MP1985PLC003039. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Raaj Medisafe India is a listed company as per MCA records. Its shares are listed on BSE (code: 524502).
Raaj Medisafe India has 5 court cases on record: 3 filed by the company and 2 filed against it. Most are in the district courts.
Raaj Medisafe India was incorporated on 12 September 1985, making it 41+ years old. It is registered with the Registrar of Companies, Gwalior.
Raaj Medisafe India has 3 deals on record (2 market trades, 1 acquisition); the latest was in March 2023.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages